dapsone has been researched along with cyclosporine in 55 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 12 (21.82) | 18.2507 |
2000's | 11 (20.00) | 29.6817 |
2010's | 31 (56.36) | 24.3611 |
2020's | 1 (1.82) | 2.80 |
Authors | Studies |
---|---|
Chang, TK; Ensom, MH; Kiang, TK | 1 |
Li, Y; Li, YH; Wang, YH; Yang, L; Yang, SL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Barber, J; Dawson, S; Kenna, JG; Paul, N; Stahl, S | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bahmer, FA | 1 |
Propper, D; Wright, V | 1 |
Diem, E; Gotschim, A; Maier, H; Ortel, B | 1 |
Conn, DL; Valente, RM | 1 |
Moss, RB | 1 |
Altes-Levy, HR; Chin-a-Lien, RA; Naafs, B | 1 |
Starink, TM; Stenveld, HJ; Stoof, TJ; van Joost, T | 1 |
Kinirons, MT; Pincus, T; Stein, CM; Wilkinson, GR; Wood, AJ | 1 |
Hatta, N; Imai, T; Sakai, H; Takata, M; Takehara, K; Tsutsui, K | 1 |
Spector, SL | 1 |
Chosidow, O; Cribier, B | 1 |
Al-Baghli, NM; Alsaleh, QA; Dvorak, R; Nanda, A | 1 |
Coulson, IH; Young, HS | 1 |
Kaklamani, VG; Kaklamanis, PG | 1 |
Arata, J; Egusa, M; Fujimoto, W; Iwatsuki, K; Kambara, H; Kuyama, M; Maehara, K; Ohara, A; Saitoh, M; Yamasaki, O | 1 |
Rosenkrantz, WS | 1 |
Wieczorek, D | 1 |
Farhi, D; Wallach, D | 1 |
Caux, F | 1 |
Bonsmann, G; Kuhn, A; Ruland, V | 1 |
Chalmers, RJ; Reddick, CL; Singh, MN | 1 |
Aiba, S; Mizuashi, M; Sugawara, M; Tanita, M | 1 |
Frew, JW; Martin, LK; Murrell, DF | 1 |
Intong, LR; Murrell, DF | 2 |
Kim, HC; Kim, MR; Kim, SC | 1 |
Fukami, Y; Honma, M; Iizuka, H; Ishida-Yamamoto, A; Takahashi, H | 1 |
Georgakopoulou, EA; Scully, C | 1 |
Allen, J; Chadwick, PR; Green, D; Lamerton, E; Middleton, R; Mitsides, N; New, D; Redshaw, J; Subudhi, CP; Wood, G | 1 |
Braun-Falco, M; Goerdt, S; Leverkus, M; Lohse, P; Pfannschmidt, N; Staub, J; Strohal, R | 1 |
Al-Ismail, D; Anderson, E; Batul Syed, S; Burden-Teh, E; Carmichael, A; Caruana, D; Darne, S; Dolman, S; Glover, M; Helbling, I; Hughes, B; Hughes, J; Jones, V; Jury, C; Kalavala, M; Katugampola, R; Lam, ML; McPherson, T; Moore, A; Murphy, R; Natarajan, S; Richards, L; Taibjee, SM; Taylor, A; Webster, S | 1 |
Gulliver, WP; van der Zee, HH | 1 |
Holm, JG; Ivyanskiy, I; Thomsen, SF | 1 |
Brassard, A; Fiorillo, L; Kuzel, P; Sotoodian, B | 1 |
Bai, JW; Fleming, P; Gulliver, WP; Partridge, ACR; Rosen, CF; Walsh, SR | 1 |
Aboud, N; Depré, F; Mayer, B; Salama, A | 1 |
Christian, W; Newell, L; Tate, C | 1 |
Gieler, U; Husein-ElAhmed, H; Steinhoff, M | 1 |
Araki, M; Hioki, T; Kamiya, H; Kitajima, Y | 1 |
Katsarou, A; Lambrou, GI; Makris, M; Nakou, E; Nicolaidou, E; Stratigos, A; Tagka, A | 1 |
17 review(s) available for dapsone and cyclosporine
Article | Year |
---|---|
UDP-glucuronosyltransferases and clinical drug-drug interactions.
Topics: Clinical Trials as Topic; Drug Interactions; Enzyme Activation; Enzyme Induction; Glucuronides; Glucuronosyltransferase; Humans; Pharmaceutical Preparations; Pharmacogenetics; Polymorphism, Genetic | 2005 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Current therapies for systemic vasculitis.
Topics: Azathioprine; Chlorambucil; Cyclophosphamide; Cyclosporine; Dapsone; Humans; Immunization, Passive; Methotrexate; Plasmapheresis; Vasculitis | 1994 |
Alternative pharmacotherapies for steroid-dependent asthma.
Topics: Adrenal Cortex Hormones; Asthma; Clinical Trials as Topic; Cyclosporine; Dapsone; Furosemide; Gold; Humans; Hydroxychloroquine; Magnesium Sulfate; Methotrexate; Treatment Outcome; Troleandomycin | 1995 |
Alternative treatments in the patient with intractable asthma.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Anti-Infective Agents; Antirheumatic Agents; Asthma; Cyclosporine; Dapsone; Humans; Hydroxychloroquine; Immunization, Passive; Immunosuppressive Agents; Methotrexate; Organogold Compounds; SRS-A; Troleandomycin | 1997 |
[Lichen].
Topics: Adrenal Cortex Hormones; Cyclosporine; Dapsone; Griseofulvin; Humans; Immunosuppressive Agents; Lichen Planus; Metronidazole; Phenytoin; PUVA Therapy; Retinoids | 1997 |
Pemphigus: current therapy.
Topics: Animals; Antirheumatic Agents; Azathioprine; Chlorambucil; Cyclophosphamide; Cyclosporine; Dapsone; Dog Diseases; Dogs; Glucocorticoids; Immunoglobulins, Intravenous; Mycophenolic Acid; Niacinamide; Organogold Compounds; Pemphigus; Sulfasalazine; Tacrolimus; Tetracycline | 2004 |
The neutrophilic dermatoses.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Biopsy; Cyclosporine; Dapsone; Dermatologic Agents; Diagnosis, Differential; Histological Techniques; Humans; Immunosuppressive Agents; Infliximab; Medical History Taking; Neutrophil Infiltration; Patient Education as Topic; Pyoderma Gangrenosum; Skin Care; Skin Diseases, Vesiculobullous; Sweet Syndrome | 2008 |
Cutaneous lupus erythematosus: update of therapeutic options part II.
Topics: Algorithms; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Clofazimine; Cyclophosphamide; Cyclosporine; Dapsone; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interferon-alpha; Isoxazoles; Leflunomide; Lenalidomide; Lupus Erythematosus, Cutaneous; Methotrexate; Mycophenolic Acid; Retinoids; Rituximab; Thalidomide; Tumor Necrosis Factor-alpha | 2011 |
Evidence-based treatments in pemphigus vulgaris and pemphigus foliaceus.
Topics: Azathioprine; Cyclophosphamide; Cyclosporine; Dapsone; Dermatologic Agents; Epidermal Growth Factor; Evidence-Based Medicine; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Medicine, Chinese Traditional; Mycophenolic Acid; Pemphigus; Pentoxifylline; Plasmapheresis; Randomized Controlled Trials as Topic; Sulfasalazine; Tacrolimus | 2011 |
Management of epidermolysis bullosa acquisita.
Topics: Antibodies, Monoclonal, Murine-Derived; Autoantibodies; Autoimmune Diseases; Chronic Disease; Colchicine; Collagen Type VII; Cyclosporine; Dapsone; Dermatologic Agents; Epidermolysis Bullosa Acquisita; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Mycophenolic Acid; Photochemotherapy; Plasmapheresis; Rituximab; Sulfapyridine; Sulfasalazine | 2011 |
Systemic use of non-biologic agents in orofacial diseases: other immunomodulatory agents.
Topics: Anti-Infective Agents; Calcineurin Inhibitors; Colchicine; Cyclophosphamide; Cyclosporine; Dapsone; Drug Interactions; Drug Monitoring; Facial Dermatoses; Humans; Immunosuppressive Agents; Mouth Diseases; Tacrolimus; Thalidomide; Tubulin Modulators | 2015 |
Successful treatment of PASH syndrome with infliximab, cyclosporine and dapsone.
Topics: Acne Vulgaris; Anti-Infective Agents; Cyclosporine; Dapsone; Dermatologic Agents; Drug Therapy, Combination; Female; Hidradenitis Suppurativa; Humans; Immunosuppressive Agents; Infliximab; Pyoderma Gangrenosum; Syndrome; Young Adult | 2015 |
Medical Treatments of Hidradenitis Suppurativa: More Options, Less Evidence.
Topics: Acitretin; Adrenal Cortex Hormones; Anti-Infective Agents; Cyclosporine; Dapsone; Dermatologic Agents; Gluconates; Hidradenitis Suppurativa; Hormones; Humans; Hypoglycemic Agents; Injections, Intralesional; Keratolytic Agents; Metformin; Ustekinumab | 2016 |
Use of nonbiologic treatments in antihistamine-refractory chronic urticaria: a review of published evidence.
Topics: Anti-Allergic Agents; Chronic Disease; Cyclosporine; Dapsone; Databases, Factual; Drug Resistance; Histamine Antagonists; Humans; Immunoglobulins, Intravenous; Plasmapheresis; Ultraviolet Therapy; Urticaria | 2018 |
Effectiveness of systemic treatments for pyoderma gangrenosum: a systematic review of observational studies and clinical trials.
Topics: Administration, Oral; Biological Products; Clinical Trials as Topic; Cyclosporine; Dapsone; Dose-Response Relationship, Drug; Glucocorticoids; Humans; Injections, Intralesional; Injections, Intravenous; Observational Studies as Topic; Pyoderma Gangrenosum; Treatment Outcome | 2018 |
Lichen planus: a comprehensive evidence-based analysis of medical treatment.
Topics: Administration, Oral; Administration, Topical; Adrenal Cortex Hormones; Antifungal Agents; Calcineurin Inhibitors; Calcitriol; Cyclosporine; Dapsone; Dermatologic Agents; Enoxaparin; Evidence-Based Medicine; Humans; Hydroxychloroquine; Lichen Planus; Methotrexate; Mycophenolic Acid; Retinoids; Tacrolimus; Ultraviolet Therapy | 2019 |
38 other study(ies) available for dapsone and cyclosporine
Article | Year |
---|---|
Modeling K(m) values using electrotopological state: substrates for cytochrome P450 3A4-mediated metabolism.
Topics: Computational Biology; Cyclohexanols; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Molecular Structure; Principal Component Analysis; Pyrrolizidine Alkaloids; Quantitative Structure-Activity Relationship; Reproducibility of Results; Substrate Specificity; Venlafaxine Hydrochloride | 2005 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Cholestasis; Drug-Related Side Effects and Adverse Reactions; Humans; Insecta; Rats; Risk Factors | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[Therapy of lymphocytic infiltration].
Topics: Azathioprine; Clofazimine; Cyclosporine; Dapsone; Humans; Levamisole; Lymphocytosis; Skin; Skin Diseases; Thalidomide | 1992 |
How should I treat a 24-year-old female with a 6-year history of relapsing polychondritis, mainly affecting the nasal cartilage, and to a lesser extent the auricular cartilages?
Topics: Adult; Cartilage; Cyclosporine; Dapsone; Ear Cartilage; Female; Humans; Nose; Polychondritis, Relapsing | 1991 |
[Pyoderma gangrenosum as a precursor of myeloid leukemia].
Topics: Adult; Combined Modality Therapy; Cyclosporine; Dapsone; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Methylprednisolone; Paraneoplastic Syndromes; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Trimester, Second; Pyoderma Gangrenosum; Recurrence; Skin Transplantation | 1995 |
Midborderline (BB)-borderline lepromatous (BL) leprosy with reversal reaction (RR).
Topics: Aged; Biopsy; Clofazimine; Cyclosporine; Dapsone; Diabetes Complications; Humans; Leprosy, Lepromatous; Male; Neurologic Examination; Prednisone; Rifampin | 1994 |
Efficacy of cyclosporine in two patients with dermatitis herpetiformis resistant to conventional therapy.
Topics: Cyclosporine; Dapsone; Dermatitis Herpetiformis; Female; Humans; Male; Middle Aged | 1993 |
Comparison of the dapsone recovery ratio and the erythromycin breath test as in vivo probes of CYP3A activity in patients with rheumatoid arthritis receiving cyclosporine.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Breath Tests; Carbon Radioisotopes; Cyclosporine; Cytochrome P-450 CYP2E1; Cytochrome P-450 Enzyme System; Dapsone; Erythromycin; Female; Humans; Male; Middle Aged; Mixed Function Oxygenases; Predictive Value of Tests; Protein Synthesis Inhibitors | 1996 |
Widespread pruritic plaques in a patient with subacute cutaneous lupus erythematosus and hypocomplementemia: response to dapsone therapy.
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Chloroquine; Complement C3; Complement System Proteins; Cyclosporine; Dapsone; Dermatologic Agents; Female; Humans; Immunoglobulin G; Immunoglobulin M; Immunosuppressive Agents; Lupus Erythematosus, Cutaneous; Methylprednisolone; Prednisolone; Pruritus; Skin Diseases, Papulosquamous | 1996 |
Pemphigus in Kuwait.
Topics: Age of Onset; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cushing Syndrome; Cyclosporine; Dapsone; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kuwait; Male; Pemphigus; Prednisolone; Remission Induction; Sex Factors; Skin; Time Factors; Treatment Outcome; Weight Gain | 1999 |
Linear IgA disease: successful treatment with cyclosporin.
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Cyclosporine; Dapsone; Dermatologic Agents; Drug Therapy, Combination; Humans; Immunoglobulin A; Male; Prednisolone; Skin Diseases, Vesiculobullous | 2000 |
Treatment of Behçet's disease--an update.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Behcet Syndrome; Chlorambucil; Colchicine; Cyclophosphamide; Cyclosporine; Dapsone; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interferons; Levamisole; Male; Methotrexate; Pentoxifylline; Recombinant Proteins; Recurrence; Sulfasalazine; Thalidomide | 2001 |
Amicrobial pustular dermatosis in two patients with immunological abnormalities.
Topics: Administration, Oral; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Autoimmune Diseases; Cyclosporine; Dapsone; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Prednisolone; Skin Diseases, Vesiculobullous | 2002 |
[Treating chronic urticaria].
Topics: Adrenal Cortex Hormones; Adult; Child; Chloroquine; Chronic Disease; Cyclosporine; Dapsone; Diagnosis, Differential; Histamine Antagonists; Humans; Pruritus; Urticaria | 2006 |
[Epidermolysis bullosa acquisita].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Autoimmune Diseases; Collagen Type VII; Crohn Disease; Cyclosporine; Dapsone; Diagnosis, Differential; Enzyme-Linked Immunosorbent Assay; Epidermolysis Bullosa Acquisita; Fluorescent Antibody Technique; Histological Techniques; Humans; Immunoblotting; Immunoglobulin A; Immunologic Factors; Microscopy, Immunoelectron; Practice Guidelines as Topic; Rare Diseases; Rituximab; Severity of Illness Index | 2010 |
Successful treatment of superficial pyoderma gangrenosum associated with hidradenitis suppurativa with adalimumab.
Topics: Adalimumab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Comorbidity; Cyclosporine; Dapsone; Hidradenitis Suppurativa; Humans; Infliximab; Male; Methylprednisolone; Middle Aged; Minocycline; Prednisolone; Pyoderma Gangrenosum; Thalidomide; Treatment Outcome | 2010 |
A case of pustular vasculopathy. An atypical variant of Sweet's syndrome?
Topics: Adult; Anti-Infective Agents; Anti-Inflammatory Agents; Cyclosporine; Dapsone; Dermatologic Agents; Diagnosis, Differential; Humans; Male; Prednisolone; Sweet Syndrome | 2010 |
Pemphigoid gestationis: current management.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Cyclophosphamide; Cyclosporine; Dapsone; Dermatologic Agents; Female; Goserelin; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Niacinamide; Pemphigoid Gestationis; Plasmapheresis; Pregnancy; Rituximab | 2011 |
Long-term prognosis of pemphigus in Korea: retrospective analysis of 199 patients.
Topics: Adult; Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Cyclophosphamide; Cyclosporine; Dapsone; Drug Therapy, Combination; Female; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Mycophenolic Acid; Pemphigus; Prednisolone; Prognosis; Republic of Korea; Retrospective Studies; Rituximab; Severity of Illness Index; Time Factors; Treatment Outcome; Young Adult | 2011 |
Successful combination therapy with dapsone and cyclosporine for erythema elevatum diutinum with unusual appearance.
Topics: Administration, Oral; Aged; Cyclosporine; Dapsone; Drug Therapy, Combination; Free Radical Scavengers; Humans; Immunosuppressive Agents; Male; Vasculitis, Leukocytoclastic, Cutaneous | 2012 |
Dapsone-induced methemoglobinemia in renal transplant recipients: more prevalent than previously thought.
Topics: Adult; Aged; Anti-Infective Agents; Azathioprine; Cohort Studies; Cyclosporine; Dapsone; Female; Glomerular Filtration Rate; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Length of Stay; Male; Methemoglobinemia; Middle Aged; Mycophenolic Acid; Pneumonia, Pneumocystis; Prednisolone; Prevalence; Regression Analysis; Risk Factors; Tacrolimus | 2014 |
How are we using systemic drugs to treat psoriasis in children? An insight into current clinical U.K. practice.
Topics: Acitretin; Adolescent; Child; Child, Preschool; Cyclosporine; Dapsone; Dermatologic Agents; Fumarates; Humans; Immunosuppressive Agents; Methotrexate; Practice Patterns, Physicians'; Psoriasis; United Kingdom | 2015 |
Disfiguring ulcerative neutrophilic dermatosis secondary to doxycycline and isotretinoin in an adolescent boy with acne conglobata.
Topics: Acne Conglobata; Adolescent; Colchicine; Cyclosporine; Dapsone; Dermatologic Agents; Doxycycline; Humans; Isotretinoin; Male; Neutrophils; Prednisone; Skin Ulcer | 2017 |
Efficacy and tolerability of old and new drugs used in the treatment of immune thrombocytopenia: Results from a long-term observation in clinical practice.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azathioprine; Benzoates; Child; Child, Preschool; Combined Modality Therapy; Cyclosporine; Dapsone; Dexamethasone; Drug Resistance; Drug Therapy, Combination; Female; Humans; Hydrazines; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Middle Aged; Prednisolone; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Receptors, Fc; Recombinant Fusion Proteins; Remission Induction; Retrospective Studies; Rho(D) Immune Globulin; Rituximab; Splenectomy; Thrombopoietin; Treatment Outcome; Young Adult | 2018 |
Chronic Bullous Dermatosis of Childhood and the String of Pearls Sign.
Topics: Biopsy, Needle; Child, Preschool; Cyclosporine; Dapsone; Diagnosis, Differential; Disease Progression; Drug Therapy, Combination; Emergency Service, Hospital; Humans; Immunohistochemistry; Linear IgA Bullous Dermatosis; Male; Prednisolone; Rare Diseases; Risk Assessment; Severity of Illness Index; Skin Diseases, Vesiculobullous; Treatment Outcome | 2018 |
Annular elastolytic giant cell granuloma associated with diabetes mellitus: a case treated with a combination of low-dose cyclosporine and dapsone.
Topics: Aged, 80 and over; Anti-Infective Agents; Cyclosporine; Dapsone; Dermatologic Agents; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Granuloma Annulare; Granuloma, Giant Cell; Humans; Male | 2019 |
Omalizumab in the Treatment of Chronic Urticaria: The Effect of Drug Co-Administration and Co-Morbidities.
Topics: Anti-Allergic Agents; Chronic Urticaria; Comorbidity; Cyclosporine; Dapsone; Drug Therapy, Combination; Female; Histamine Antagonists; Humans; Male; Omalizumab; Recurrence; Sex Factors | 2021 |